Iterum Therapeutics plc (ITRMF)

Iterum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11	24.13	6.07	21.09	27.45	14.51
Short-Term Investments	-	-	17.86	39.71	53.94	2.36
Cash & Short-Term Investments	11	24.13	23.93	60.8	81.38	16.87
Cash Growth	-24.14%	0.81%	-60.64%	-25.29%	382.46%	183.97%
Other Receivables	0.1	0.07	0.23	0.42	1.21	3.74
Receivables	0.55	0.07	0.23	0.42	1.21	3.74
Prepaid Expenses	1.03	0.53	1.43	1.22	0.68	0.8
Restricted Cash	-	-	-	-	-	0.06
Other Current Assets	-	0.07	-	-	-	-
Total Current Assets	13.73	24.79	25.6	62.44	83.27	21.47
Property, Plant & Equipment	0.02	0.02	0.6	1.84	3.83	5.68
Other Intangible Assets	18.71	19.75	-	1.72	3.44	-
Other Long-Term Assets	0.05	0.04	0.06	0.83	0.98	5.64
Total Assets	32.5	44.6	26.26	66.83	91.51	32.79

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	0.58	0.25	5	2.77	0.88	0.82
Accrued Expenses	5.22	2.65	7.76	4.35	1.17	1.83
Short-Term Debt	-	14.46	-	-	-	-
Current Portion of Long-Term Debt	0.28	-	-	-	1.63	6.49
Current Portion of Leases	-	0.07	0.37	0.33	0.46	0.57
Current Income Taxes Payable	0.02	-	-	-	0.22	0.1
Other Current Liabilities	0.33	0.17	0.4	1.61	8.59	31.89
Total Current Liabilities	6.43	17.61	13.52	9.06	12.94	41.7
Long-Term Debt	33.45	31.07	18.96	28.47	24.9	35.85
Long-Term Leases	-	-	0.19	1.3	3.44	5.17
Other Long-Term Liabilities	-	-	-	-	-	0.63
Total Liabilities	39.88	48.68	32.66	38.83	41.28	83.35

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.49	0.32	0.14	0.13	0.12	0.49
Additional Paid-In Capital	498.58	481.68	454.76	451.15	428.61	235.88
Retained Earnings	-506.45	-486.07	-461.3	-422.93	-378.49	-286.93
Comprehensive Income & Other	-	-	0	-0.35	-	-
Total Common Equity	-7.38	-4.08	-6.4	28	50.23	-50.56
Shareholders' Equity	-7.38	-4.08	-6.4	28	50.23	-50.56
Total Liabilities & Equity	32.5	44.6	26.26	66.83	91.51	32.79

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	33.74	45.6	19.51	30.1	30.43	48.08
Net Cash (Debt)	-22.73	-21.48	4.42	30.7	50.96	-31.22
Net Cash Growth	-	-	-85.60%	-39.75%	-	-
Net Cash Per Share	-0.62	-1.09	0.34	2.51	4.68	-19.50
Filing Date Shares Outstanding	52.79	34.58	16.43	12.71	12.19	11.77
Total Common Shares Outstanding	48.99	31.53	13.5	12.6	12.19	3.3
Working Capital	7.3	7.18	12.08	53.38	70.33	-20.23
Book Value Per Share	-0.15	-0.13	-0.47	2.22	4.12	-15.34
Tangible Book Value	-26.09	-23.83	-6.4	26.28	46.8	-50.56
Tangible Book Value Per Share	-0.53	-0.76	-0.47	2.09	3.84	-15.34
Machinery	0.11	0.22	0.22	0.21	0.23	0.34
Leasehold Improvements	-	0.15	0.15	0.15	0.15	0.59

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error